Indications
Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone; treatment of adult patients with tumour-induced hypercalcaemia (TIH).
Composition
- Active substance
- zoledronic acid
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zoledronic acid Mylan
- Active substance
- zoledronic acid
- ATC code
- M05BA08
- Therapeutic area
- Fractures, Bone
- Marketing authorisation holder
- Mylan Pharmaceuticals Limited